Private Equity Acquisition Effect on the Most Common Urologic Procedures.
Complex cystometrogram volume rose more after 2018 private equity acquisition than in controls
Private Equity Acquisition Effect on the Most Common Urologic Procedures.
To examine the impact of private equity (private equity) acquisition on the volume of common outpatient urologic procedures.
Private equity acquisitions of urology practices in 2016 and 2018 were identified through use of financial databases cataloguing both public and private transactions.
We identified 199 and 196 physicians acquired by private equity and not acquired, respectively.
For some procedures (cystoscopy, post-void residual, prostate biopsy, complex cystometrogram, complex uroflow), the post-acquisition trends in volume were different for those acquired in 2018 compared to the control groups.
The number of new patient and follow-up office visits were largely unaffected by private equity acquisition in 2016 and 2018.
We observed variability in procedure volumes after private equity acquisition, depending on the procedure type. The full impact of the changing ownership model in urology is yet to be determined.